The use of nitric oxide donors in pharmacological studies

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 358, Issue 1, 1998, Pages 113-122

  Feelisch, Martin ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYL NITRITE; GLYCERYL TRINITRATE; HEMOGLOBIN; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; S NITROSOTHIOL; SYDNONIMINE DERIVATIVE; UNCLASSIFIED DRUG;

CHEMICAL REACTION KINETICS; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR DYNAMICS; OXIDATION; REACTION ANALYSIS; REGULATORY MECHANISM; REVIEW; VASODILATATION;

ANIMALS; GLUTATHIONE; HUMANS; MOLSIDOMINE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; NITROSO COMPOUNDS; PENICILLAMINE; S-NITROSOGLUTATHIONE;

EID: 0031866842     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005231     Document Type: Review

References (77)

1. Ahlner J, Andersson RGG, Torfgård K, Axelsson KL (1991) Organic nitrate esters: clinical use and mechanisms of actions. Pharmacol Rev 43:351-423
2. Aissa J, Feelisch M (1992) Generation of nitric oxide accounts for the anti-platelet effect of organic nitrates - the role of plasma components and vascular cells. In: Moncada S, Marletta MA, Hibbs JB, Higgs EA (eds) The biology of nitric oxide. I. Physiological and clinical aspects. Portland Press, Colchester, pp 142-144
3. +, NO and NO donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys 318:279-285
4. Bates JN, Baker MT, Guerra R Jr, Harrison DG (1991) Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem Pharmacol 42:5157-5165
5. Beckman JS, Wink DA, Crow JP (1996) Nitric oxide and peroxynitrite. In: Feelisch M, Stamler JS (eds) Methods in nitric oxide research. Wiley, Chichester, pp 61-70
6. Bennett BM, McDonald BJ, Nigam R, Simon WC (1994) Biotransformation of organic nitrates and vascular smooth muscle cell function. Trends Pharmacol Sci 15:245-249
7. Boesgaard S, Aldershvile J, Poulsen HE, Loft S, Anderson ME, Meister A (1994) Nitrate tolerance in vivo is not associated with depletion of arterial or venous thiol levels. Circ Res 74:115-120
8. Bohn H, Schönafinger K (1989) Oxygen and oxidation promote the release of nitric oxide from sydnonimines. J Cardiovasc Pharmacol 14:S6-S12
9. Bohn H, Beyerle R, Martorana PA, Schönafinger K (1991) CAS 936, a novel syndnonimine with direct vasodilating and nitric oxide-donating properties: effects on isolated blood vessels. J Cardiovasc Pharmacol 18:522-527
10. Carter MH, Josephy PD (1986) Mutagenicity of thionitrites in the Ames test. The biological activity of thioyl free radicals. Biochem Pharmacol 35:3847-3851
11. Chong S, Fung HL (1991) Biochemical and pharmacological interactions between nitroglycerin and thiols. Effects of thiol structure on nitric oxide generation and tolerance reversal. Biochem Pharmacol 42:1433-1439
12. Chung SJ, Chong S, Seth P, Jung CY, Fung HL (1992) Conversion of nitroglycerin to nitric oxide in microsomes of the bovine coronary artery smooth muscle is not primarily mediated by glutathione-S-transferases. J Pharmacol Exp Ther 260:652-659
13. Darley-Usmar VM, Hogg N, O'Leary VJ, Wilson MT, Moncada S (1992) The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Rad Res Commun 17:9-20
14. + as the effective reagent in nitric oxide formation from S-nitrosothiols (RSNO). J Chem Soc Perkin Trans 2:481-487
15. Doyle MP, Hoekstra JW (1984) Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. J Inorg Chem 14:351-358
16. Feelisch M (1991) The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J Cardiovasc Pharmacol 17:S25-S33
17. Feelisch M (1993) Biotransformation to nitric oxide of organic nitrates in comparison to other nitrovasodilators. Eur Heart J 14:123-132
18. Feelisch M, Kelm M (1991) Biotransformation of organic nitrates to nitric oxide by vascular smooth muscle and endothelial cells. Biochem Biophys Res Commun 180:286-293
19. Feelisch M, Stamler JS (1996) Donors of nitrogen oxides. In: Feelisch M, Stamler JS (eds) Methods in nitric oxide research Wiley, Chichester, pp 71-115
20. Feelisch M, Noack E, Schröder H (1988) Explanation of the discrepancy between the degree of organic nitrate decomposition, nitrite formation and guanylate cyclase stimulation. Eur Heart J 9:57-62
21. Feelisch M, Ostrowski J, Noack E (1989) On the mechanism of NO release from sydnonimines. J Cardiovasc Pharmacol 14:513-522
22. Field L, Dilts RV, Ravichandran R, Lenhert PG, Carnahan GE (1978) An unusually stable thionitrite from N-acetyl-D,L-penicillamine; X-ray crystal and molecular structure of 2-(acetylamino)-2-carboxy-1,1-dimethylethyl thionitrite. J Chem Soc Chem Commun 1157:249-252
23. Gaston B, Reilly J, Drazen JM, Fackler J, Ramdev P, Arnelle D, Mullins ME, Sugarbaker DJ, Chee C, Singel DJ, Loscalzo J, Stamler JS (1993) Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci USA 90:10957-10961
24. Gaston B, Drazen JM, Jansen A, Sugarbaker DA, Loscalzo J, Richards W, Stamler JS (1994) Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro. J Pharmacol Exp Ther 268:978-984
25. Gordge MP, Meyer DJ, Hothersall J, Neild GH, Payne NN, Noronha-Dutra A (1995) Copper chelation-induced reduction of the biological activity of S-nitrosothiols. Br J Pharmacol 114:1083-1089
26. Gorren ACF, Schrammel A, Schmidt K, Mayer B (1996) Decomposition of S-nitrosogluathione in the presence of copper and glutathione. Arch Biochem Biophys 330:219-228
27. Gruetter CA, Lemke SM (1985) Dissociation of cysteine and glutathione levels from nitroglycerin-induced relaxation. Eur J Pharmacol 111:85-95
28. Haefeli WE, Srivastava N, Kelsey KT, Wiencke JK, Hoffman BB, Blaschke TF (1993) Glutathione S-transferase mu polymorphism does not explain variation in nitroglycerin responsiveness. Clin Pharmacol Ther 53:463-468
29. Harrison DG, Bates JN (1993) The nitrovasodilators. New ideas about old drugs. Circulation 87:1461-1467
30. Hart TW (1985) Some observations concerning the S-nitroso and S-phenylsulfonyl derivatives of L-cysteine and glutathione. Tetrahedr Lett 26:2013-2016
31. Hebert D, Xiang JX, Lam JY (1997) Persistent inhibition of platelets during continuous nitroglycerin therapy despite hemodynamic tolerance. Circulation 95:1308-1313
32. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S (1992) Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J 281:419-424
33. Huie RE, Padmaja S (1993) The reaction of NO with superoxide. Free Rad Res Commun 18:195-199
34. Kaltenbach M, Schneider W (1986) Fortbestehen der antianginösen Wirksamkeit unter chronischer Nitrattherapie trotz Aufhebung hämodynamischer Teileffekte. Dtsch Med Wochenschr 111:383-386
35. Kankaanranta H, Knowles RG, Vuorinen P, Kosonen O, Holm P, Moilanen E (1997) 3-Morpholino-sydnonimine-induced suppression of human neutrophil degranulation is not mediated by cyclic GMP, nitric oxide, or peroxynitrite: inhibition of the increase in intracellular free calcium concentration by N-morpholino-iminoacetonitrile, a metabolite of 3-morpholino-sydnonimine. Mol Pharmacol 51:882-888
36. Kenkare SR, Han C, Benet LZ (1994) Correlation of the response to nitroglycerin in rabbit aorta with the activity of the mu class glutathione S-transferase. Biochem Pharmacol 48:2231-2235
37. Kharitonov VG, Sundquist AR, Sharma VS (1994) Kinetics of nitric oxide autoxidation in aqueous solution. J Biol Chem 8:5881-5883
38. Kleshchev AL, Mordvintsev PJ, Shabarchina MM, Vanin AF (1985) Reduction of sodium nitroprusside with the subsequent elimination of nitric oxide in animals. Zh Fiz Khim 59:462-467
39. Kowaluk EA, Fung HL (1990) Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J Pharmacol Exp Ther 255:1256-1264
40. Kowaluk EA, Seth P, Fung HL (1992) Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle. J Pharmacol Exp Ther 262:916-922
41. Kurz MA, Lamping KG, Bates JN, Eastham CL, Marcus ML, Harrison DG (1991) Mechanisms responsible for heterogeneous coronary microvascular response to nitroglycerin. Circ Res 68:847-855
42. 2 formation. Biochem J 292:545-550
43. Liu Z, Brien JF, Marks GS, McLaughlin BE, Nakatsu K (1993) Lack of evidence for the involvement of cytochrome P-450 or other hemoproteins in metabolic activation of glyceryl trinitrate in rabbit aorta. J Pharmacol Exp Ther 264:1432-1439
44. Maragos CM, Morley D, Wink DA, Dunams TM, Saavedra JE, Hoffman A, Bove AA, Isaac L, Hrabie JA, Keefer LK (1991) Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem 34:3242-3247
45. Maragos CM, Wang JM, Hrabie JA, Oppenheim JJ, Keefer LK (1993) Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release. Cancer Res 53:564-568
46. Mathews WR, Kerr SW (1993) Biological activity of S-nitrosothiols: the role of nitric oxide. J Pharmacol Exp Ther 267:1529-1537
47. McAninly J, Williams DLH, Askew SC, Butler AR, Russell C (1993) Metal ion catalysis in nitrosothiol (RSNO) decomposition. J Chem Soc Chem Commun 1758-1759
48. McDonald BJ, Bennett BM (1993) Biotransformation of glyceryl trinitrate by rat aortic cytochrome P450. Biochem Pharmacol 45:268-270
49. McGuire JJ, Anderson DJ, Bennet BM (1994) Inhibition of the biotransformation and pharmacological actions of glyceryl trinitrate by the flavoprotein inhibitor, diphenyleneiodonium sulfate. J Pharmacol Exp Ther 271:708-714
50. Miyauchi N, Takahashi M, Hujioka H, Kinoshita M (1993) Dissociation of hemodynamic and coronary arterial tolerance to nitroglycerin in dogs. J Cardiovasc Pharmacol 21:767-773
51. Mohazzab-H KM, Gurrant CE, Wolin MS (1992) Microsomal NADH-oxidoreductase mediates nitric oxide release and relaxation to nitroprusside in the calf pulmonary artery. Circulation 86:1489 (abstract)
52. Mooradian DL, Hutsell TC, Keefer LK (1995) Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol 25:674-678
53. Morley D, Keefer LK (1993) Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators. J Cardiovasc Pharmacol 22:S3-S9
54. Mülsch A, Lückhoff A, Pohl U, Busse R, Bassenge E (1989) LY 83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation. Naunyn Schmiedebergs Arch Pharmacol 340:119-125
55. Mülsch A, Hecker M, Mordvintcev PI, Vanin AF, Busse R (1993) Enzymic and nonenzymic release of NO accounts for the vasodilator activity of the metabolites of CAS 936, a novel long-acting sydnonimine derivative. Naunyn Schmiedebergs Arch Pharmacol 347:92-100
56. Noack E, Feelisch M (1989) Molecular aspects underlying the vasodilator action of molsidomine. J Cardiovasc Pharmacol 14:S1-S5
57. Ramamurthi A, Lewis RS (1997) Measurement and modeling of nitric oxide release rates for nitric oxide donors. Chem Res Toxicol 10:408-113
58. Rao DNR, Elguindi S, O'Brien PJ (1991) Reductive metabolism of nitroprusside in rat hepatocytes and human erythrocytes. Arch Biochem Biophys 286:30-37
59. Rochelle LG, Kruszyna H, Kruszyna R, Barchowsky A, Wilcox DE, Smith RP (1994) Bioactivation of nitroprusside by porcine endothelial cells. Toxicol Appl Pharmacol 28:123-128
60. Saavedra JE, Dunams TM, Flippen-Anderson JL, Keefer LK (1992) Secondary amine/nitric oxide complex ions R2N[N(O)NO] O-functionalization chemistry. J Org Chem 57:6134-6138
61. Saavedra JE, Billiar TR, Williams DL, Kim YM, Watkins SC, Keefer LK (1997) Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver. J Med Chem 40:1947-1954
62. Salas E, Moro MA, Askew S, Hodson HF, Butler AR, Radomski MW, Moncada S (1994) Comparative pharmacology of analogues of S-nitroso-N-acetyl-D,L-penicillamine on human platelets. Br J Pharmacol 112:1071-1076
63. Schmidt K, Desch W, Klatt P, Kukovetz WR, Mayer B (1997) Release of nitric oxide from donors with known half-life: a mathematical model for calculating nitric oxide concentrations in aerobic solutions. Naunyn Schmiedbergs Arch Pharmacol 355:457-462
64. Schröder H (1992) Cytochrome P-450 mediates bioactivation of organic nitrates. J Pharmacol Exp Ther 262:298-302
65. Seth P, Fung HL (1993) Biochemical characterization of a membrane-bound enzyme responsible for generating nitric oxide from nitro-glycerin in vascular smooth muscle cells. Biochem Pharmacol 46:1481-1486
66. Stamler JS (1995) S-nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups. Curr Topics Microbiol Immunol 196:19-36
67. Stamler JS, Feelisch M (1996) Preparation and detection of S-nitrosothiols. In: Feelisch M, Stamler JS (eds) Methods in nitric oxide research. Wiley, Chichester, pp 521-539
68. Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T, Singel DJ, Loscalzo J (1992a) S-nitrosylation of proteins with nitric oxide: synthesis and characterisation of biologically active compounds. Proc Nail Acad Sci USA 89:444-448
69. Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, Singel D, Valeri CR, Loscalzo J (1992b) Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 89:7674-7677
70. Taylor T, Taylor IW, Chasseaud LF, Bonn R (1987) Pharmacokinetics and metabolism of organic nitrate vasodilators. Prog Drug Metab 10:207-336
71. Torfgard KE, Ahlner J (1994) Mechanisms of action of nitrates. Cardiovasc Drugs Ther 8:701-717
72. Vikmon M, Szente L, Géczy J, Bult H, Malinski T, Feelisch M (1995) SIN-1A/cyclodextrin complexes. Novel, stable and biologically active NO releasing agents. Endothelium 3:S68 (abstract)
73. Werringloer J, Wolf J, Gans G (1990) Concomitant release of nitric oxide and generation of superoxide during the non-enzymatic decay of SIN-1. Eur J Pharmacol 183:1616
74. Wheatley RM, Dockery SP, Kurz MA, Sayegh HS, Harrison DG (1994) Interactions of nitroglycerin and sulfhydryl-donating compounds in coronary microvessels. Am J Physiol 266:H291-H297
75. Wolin MS, Cherry PD, Rodenburg JM, Messina EJ, Kaley G (1990) Methylene blue inhibits vasodilation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion. J Pharmacol Exp Ther 254:872-876
76. Yeates RA, Laufen H, Leitold M (1985) The reaction between organic nitrates and sulfhydryl compounds. A possible model system for the activation of organic nitrates. Mol Pharmacol 28:555-559
77. Yoshida M, Akaike T, Wada Y, Sato K, Ikeda K, Ueda S, Maeda H (1994) Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenginsi activity. Biochem Biophys Res Commun 202:923-930